Zobrazeno 1 - 10
of 21
pro vyhledávání: '"Ryan H, Cunnington"'
Autor:
Henry J. Duff, Jameson A. Dundas, Daniyil A. Svystonyuk, D. Park, Guoqi Teng, Simranjit S. Pattar, Subodh Verma, Darrell D. Belke, Jason R.B. Dyck, Paul W.M. Fedak, Ryan H. Cunnington, Sean Kang, David G. Guzzardi, Jeannine D. Turnbull, Ali Fatehi Hassanabad, Lee Anne Tibbles
Publikováno v:
Canadian Journal of Cardiology. 36:543-553
Background Empagliflozin, an SGLT2 inhibitor, has shown remarkable reductions in cardiovascular mortality and heart failure admissions (EMPA-REG OUTCOME). However, the mechanism underlying the heart failure protective effects of empagliflozin remains
Autor:
Lee Anne Tibbles, Minal Borkar-Tripathi, Vikas Srivastava, Steven C. Greenway, Ryan H. Cunnington
Publikováno v:
Transplantation. 102:S29-S30
Autor:
Lee Anne Tibbles, Vikas Srivastava, Minal Borkar-Tripathi, Steven C. Greenway, Ryan H. Cunnington
Publikováno v:
Transplantation. 102:S30
Publikováno v:
Canadian Journal of Physiology and Pharmacology. 87:764-772
Recent studies demonstrate the critical role of the extracellular matrix in the organization of parenchymal cells in the heart. Thus, an understanding of the modes of regulation of matrix production by cardiac myofibroblasts is essential. Transformin
Autor:
Kristen M. Bedosky, Ryan H. Cunnington, Ian M.C. Dixon, Jelena Komljenovic, Sunil G. Rattan, Cicie Deng, Joshua E. Raizman, Darren H. Freed, Rose Chang
Publikováno v:
Journal of Cellular Physiology. 213:540-551
Cardiac ventricular myofibroblast motility, proliferation, and contraction contribute to post-myocardial infarct wound healing, infarct scar formation, and remodeling of the ventricle remote to the site of infarction. The Na+-Ca2+ exchanger (NCX1) is
Publikováno v:
Cardiac Fibrosis and Heart Failure: Cause or Effect? ISBN: 9783319174365
Cardiac Fibrosis and Heart Failure: Cause or Effect?
Cardiac Fibrosis and Heart Failure: Cause or Effect?
Cardiac fibrosis is the pathological accumulation of cardiac extracellular matrix (ECM or matrix), which occurs in most types of heart disease. Major recent advances in our understanding have allowed us to identify cardiac fibrosis as a primary disea
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::a431e69566ed353448166a275e861f11
https://doi.org/10.1007/978-3-319-17437-2_1
https://doi.org/10.1007/978-3-319-17437-2_1
Publikováno v:
Cardiovascular Research. 65:782-792
Ischemic heart disease is the most common cause of mortality worldwide. Cardiac fibroblasts and myofibroblasts, i.e., the hypersecretory, muscular, and contractile fibroblastic phenotype variant, play an important role in myocardial healing and are r
Autor:
Ryan H. Cunnington, Ian M.C. Dixon
Publikováno v:
Hypertension. 58:142-144
See related article, pp 264–270 The term “fibroblast” designates a highly heterogenous group of cells that exhibit distinct differentiated phenotypes in different organs.1 The study of fibroblast and myofibroblast biology in specific organs is
Autor:
Sunil G. Rattan, Fahmida Jahan, David Cheung, Ryan H. Cunnington, Jeffrey T. Wigle, Ian M.C. Dixon, Krista L. Filomeno, Josette M. Northcott
Publikováno v:
The FASEB Journal. 28
The fibroblast to myofibroblast phenoconversion, which is induced by TGF-β, is a crucial step during cardiac fibrosis. Activated myofibroblasts increase extracellular matrix (ECM) synthesis, which ...
Autor:
Saeid Ghavami, Jared J.L. Davies, Krista L. Filomeno, Jeffrey T. Wigle, Ryan H. Cunnington, Ian M.C. Dixon, Josette M. Northcott, Fahmida Jahan, Morvarid S. Kavosh
Publikováno v:
Journal of cell science. 127(Pt 1)
Cardiac fibrosis is linked to fibroblast-to-myofibroblast phenoconversion and proliferation but the mechanisms underlying this are poorly understood. Ski is a negative regulator of TGF-β-Smad signaling in myofibroblasts, and might redirect the myofi